First Bank & Trust Organon & Co. Transaction History

First Bank & Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$31.66 - $38.9 $253 - $311	-8 Reduced 14.81%	46 $2,000
Q1 2022 Apr 29, 2022	SELL	$30.45 - $39.36 $1,887 - $2,440	-62 Reduced 53.45%	54 $2,000
Q4 2021 Feb 01, 2022	SELL	$28.67 - $37.13 $59,776 - $77,416	-2,085 Reduced 94.73%	116 $4,000
Q3 2021 Oct 18, 2021	BUY	$28.63 - $35.64 $6,212 - $7,733	217 Added 10.94%	2,201 $72,000
Q2 2021 Aug 10, 2021	BUY	$28.45 - $38.0 $56,444 - $75,392	1,984 New	1,984 $60,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on First Bank & Trust with notifications on news.